VSP, AOA set forum on stand-alone vision coverage

Article

VSP Global and the American Optometric Association will meet in an open forum here on Thursday, May 24, to discuss their divergent views on stand-alone vision plans participating in state health exchanges.

ST. LOUIS-VSP Global and the American Optometric Association will meet in an open forum here on Thursday, May 24, to discuss their divergent views on stand-alone vision plans participating in state health exchanges. The forum will be 6:30 to 8 p.m. CST at the St. Louis Airport Marriott Hotel.

Meeting host VSP said it will simulcast the forum to its membership, which includes more than 28,000 doctors.

VSP has set up a link to register for the forum, and posted its invitation letter to AOA leaders.

“Over 100 million people receive their eyecare today through stand-alone vision plans.  VSP thinks it's important that optometry has access to all patients, including those purchasing coverage through the Exchanges,” VSP Global Board Chairman Stuart Thomas, OD, said.

The lineup

Representing VSP at the forum will be CEO Rob Lynch, Tim Jankowski, OD, FAAO, immediate past chair, and Dan Mannen, OD, FAAO, board of directors. Participating on behalf of the AOA will be Stephen Montaquila, OD, chair, Third Party Center Executive Committee; Robert L. Jarrell, OD, chair, AOA State Government Relations Center Executive Committee; and Roger Jordan, OD, chair, AOA Federal Relations Committee.

At issue is whether doctors not affiliated with qualified health insurance plans will be able to participate in the state exchanges.

“Vision plans can participate in the health insurance exchange in every state by partnering with a qualified health plan and agreeing that eye health care is best provided by integration of the vision and medical care we provide,” AOA President Dori Carlson, OD, said.  “There is no provision anywhere in the law that seeks to limit or eliminate anyone’s vision coverage.  In fact, it expands coverage and patient access to optometric care.”

Combining vision with medical health care is the point where both groups concur.

“VSP is 1,000 percent in agreement with the AOA on the concept of integrating vision within the medical model,” Dr. Thomas said. “However, health plans don’t have a history of allowing all optometrists to participate and paying us fairly. They make money by decreasing utilization and decreasing pay to providers. There is no guarantee in the new model that optometrists will be able to participate and have payment parity with medical physicians.

For more articles in this issue of InDispensable, click here.

Recent Videos
Cecilia Koetting, OD, FAAO, DipABO, cited data from a recent student that found that presbyopia treatment with 0.4% pilocarpine led to up to 86% of patients achieving 20/40 or better.
Kerry Giedd, OD, MS, FAAO, was 1 of 20 investigators around the country for a study evaluating the daily disposable contact lens.
According to A. Paul Chous, MA, OD, FAAO, optometrists have an important opportunity to educate patients in their chairs about diabetes.
David Geffen, OD, FAAO, gave a poster presentation titled "Revolutionizing Comfort: Unveiling the Potential of Perfluorohexyloctane Eyedrops for Contact Lens Wearers" at this year's Academy meeting.
Jessica Steen, OD, FAAO, Dipl-ABO, discussed ophthalmic considerations for patients undergoing treatment with antibody drug conjugates for gynecologic cancers at this year's conference.
A. Paul Chous, MA, OD, FAAO, details a presentation on this year's updates on diabetes given at this year's Academy meeting
Sherrol Reynolds, OD, FAAO, said that multimodel imaging has been a game changer in assessing the choroidal function and structural changes in various disease conditions.
Susan Gromacki, OD, FAAO, FSLS, provides key takeaways from this year's American Academy of Optometry symposium genetics and the cornea.
Roya Attar gives an overview of her presentation, "Decoding the Retina: The Value of Genetic Testing In Inherited Disorders," presented with Mohammad Rafieetary, OD, FAAO, FORS, ABO, ABCMO.
Ian Ben Gaddie, OD, FAAO, outlines key findings from a recent study evaluating lotilaner in patients with Demodex blepharitis and meibomian gland dysfunction.
© 2024 MJH Life Sciences

All rights reserved.